Thomas McNerney & Partners LP
10% Owner

Thomas McNerney & Partners LP insider trades: Clarus Therapeutics (CRXT) stock buys and sales

10% Owner, Clarus Therapeutics Last trade Apr 20, 2022 6 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2010
4
Companies
last trade 2022

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Thomas McNerney & Partners LP reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Apr 20, 2022CRXT↓ Sell$9.5M
Apr 6, 2011TZYM↑ Buy$3.2M
Apr 6, 2011TZYM↑ Buy$58K
Apr 6, 2011TZYM↑ Buy$12K
Nov 29, 2010ZGNX↑ Buy$2.1M
Nov 29, 2010ZGNX↑ Buy$22K
Nov 29, 2010ZGNX↑ Buy$8K
Nov 29, 2010ZGNX↑ Buy$694K
Nov 29, 2010ZGNX↑ Buy$13K
Nov 29, 2010ZGNX↑ Buy$3K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Thomas McNerney & Partners LP's insider trades

Thomas McNerney & Partners LP is a 10% owner of Clarus Therapeutics (CRXT). Since Nov 29, 2010, it has reported 9 open-market purchases worth $6.1M and 1 sale worth $9.5M on SEC Form 4. There have been no open-market trades in the last 12 months.

Its filings also include conversions (4 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CRXT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.